Completed

Phase 2
Age: 18Years - 55Years
MALE
ID00000269

Pergolide Treatment for Substance Abusers

Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12

N/A

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

N

National Institute on Drug Abuse (NIDA)

Lead Sponsor

N

New York State Psychiatric Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.

CONDITIONS

Official Title

Pergolide Treatment for Substance Abusers - 4

Who Can Participate

Age: 18Years - 55Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

Please contact site for information.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 1 location

1

New York State Psychiatric Institute

New York, New York, United States, 10032

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here